Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (61-70 of 1,279) with videos related to

Pageof 128
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|July 3, 2010
Renal cell cancer: state of the art in adjuvant therapySebastiano Buti, Rodrigo K Rovere
Urologic Oncology|April 17, 2022
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice?Sebastiano Buti, Giulia Claire Giudice
Gastroenterologia Y Hepatologia|July 29, 2014
[Hepatitis B virus infection in pregnancy and the immunosuppressed patient]Mar Riveiro-Barciela, María Buti
Revista Espanola De Sanidad Penitenciaria|April 12, 2022
Prisons: an important link in the elimination of Hepatitis BA Barreira-Díaz, M Buti
Annals of Surgical Oncology|June 4, 2024
Comparing a Part with the Whole: Beware of the Disparity of the Renal Cell Carcinoma Prognostic ModelsSebastiano Buti, Giulia Claire Giudice
Antiviral Therapy|February 22, 2021
COVID-19 and hepatitis B infectionSaleh A Alqahtani, Maria Buti
Immunotherapy|October 26, 2017
The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockadeMelissa Bersanelli, Alessandro Leonetti, Sebastiano Buti
The New England Journal of Medicine|July 19, 2013
Colony-stimulating factors for febrile neutropeniaSebastiano Buti, Angelica Sikokis, Andrea Ardizzoni
Revista Clinica Espanola|June 5, 2001
[Treatment of viral hepatitis]G Olive, M Buti, R Esteban
Future Oncology (London, England)|August 2, 2018
Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)Alessandro Leonetti, Teresa Zielli, Sebastiano Buti
Pageof 128

Showing results (61-70 of 1,279) with videos related to

Sort By:
Pageof 128
Recent Patents on Anti-Cancer Drug Discovery|July 3, 2010
Renal cell cancer: state of the art in adjuvant therapySebastiano Buti, Rodrigo K Rovere
Urologic Oncology|April 17, 2022
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice?Sebastiano Buti, Giulia Claire Giudice
Gastroenterologia Y Hepatologia|July 29, 2014
[Hepatitis B virus infection in pregnancy and the immunosuppressed patient]Mar Riveiro-Barciela, María Buti
Revista Espanola De Sanidad Penitenciaria|April 12, 2022
Prisons: an important link in the elimination of Hepatitis BA Barreira-Díaz, M Buti
Annals of Surgical Oncology|June 4, 2024
Comparing a Part with the Whole: Beware of the Disparity of the Renal Cell Carcinoma Prognostic ModelsSebastiano Buti, Giulia Claire Giudice
Antiviral Therapy|February 22, 2021
COVID-19 and hepatitis B infectionSaleh A Alqahtani, Maria Buti
Immunotherapy|October 26, 2017
The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockadeMelissa Bersanelli, Alessandro Leonetti, Sebastiano Buti
The New England Journal of Medicine|July 19, 2013
Colony-stimulating factors for febrile neutropeniaSebastiano Buti, Angelica Sikokis, Andrea Ardizzoni
Revista Clinica Espanola|June 5, 2001
[Treatment of viral hepatitis]G Olive, M Buti, R Esteban
Future Oncology (London, England)|August 2, 2018
Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)Alessandro Leonetti, Teresa Zielli, Sebastiano Buti
Pageof 128